30/10/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
03/08/23 GSK Nigeria calls an end to its business, to return cash RE
03/08/23 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
03/08/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
28/04/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
27/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
27/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/10/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
29/07/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
28/04/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
31/01/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
25/10/21 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
29/07/21 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 31/07/2011
General Counsel - 31/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
-0.61%-3.43%+39.40%+112.31% 1,025B
-1.02%-5.60%+37.67%+65.02% 623B
+1.11%-0.58%+11.10%+77.28% 459B
+0.34%-3.01%+61.21%+40.71% 355B
-0.95%-4.87%+22.46%+38.03% 336B
-1.46%-2.20%+11.84%+23.94% 270B
-1.35%-4.27%-4.55%+6.92% 247B
-1.04%-2.79%+35.52%+51.34% 220B
-1.87%-4.10%+30.92%+95.33% 183B
Average -0.68%-1.89%+27.28%+56.77% 413.14B
Weighted average by Cap. -0.49%-2.11%+30.60%+68.66%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock